Stock AMGN AMGEN INC.
Add to a list

ETFs Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/04/2026 BST 		5-day change 1st Jan Change
351.02 USD -1.29% Intraday chart for Amgen Inc. +0.89% +7.24%
04-10 BeOne Medicines Says Tarlatamab Received Marketing Authorization in China for Small Cell Lung Cancer Treatment MT
04-10 Wall Street Gets a CPI Lifeline Zonebourse

ETFs positioned on Amgen Inc.

Name Varia. Jan 1. Weight AuM
NOMURA NEXT FUNDS DOW JONES INDUSTRIAL AVERAGE ETF - JPY ETF Nomura NEXT FUNDS Dow Jones Industrial Average ETF - JPY
+0.71%5.08% 136 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Yen-Hedged) ETF - JPY
-1.92%3.71% 26 M€
FIRST TRUST NYSE ARCA BIOTECHNOLOGY ETF - CAD ETF First Trust NYSE Arca Biotechnology ETF - CAD
-.--%3.24% 1 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD ETF First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD
-.--%1.65% 4 M€
VICTORYSHARES US EQ INCOME ENHANCED VOLATILITY WTD ETF - USD ETF VictoryShares US EQ Income Enhanced Volatility Wtd ETF - USD
+8.90%1.55% 615 M€
LEVERAGE SHARES -5X SHORT NASDAQ 100 ETP - USD ETF Leverage Shares -5x Short Nasdaq 100 ETP - USD
-8.71%1.29% 5 M€
LEVERAGE SHARES PUBLIC LIMITED COMPANY - 3X LONG US TECH 100 ETP ETF Leverage Shares Public Limited Company - 3x Long US Tech 100 ETP
-.--%1.29% 2 M€
LEVERAGE SHARES 5X LONG NASDAQ 100 ETP - USD ETF Leverage Shares 5x Long Nasdaq 100 ETP - USD
0.00%1.19% 29 M€
DIREXION NASDAQ-100 EQUAL WEIGHTED ETF - USD ETF Direxion NASDAQ-100 Equal Weighted ETF - USD
-1.16%1.04% 1,034 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED ETF First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD Hedged
-.--%0.88% 2 M€
HAMILTON ENHANCED MULTI-SECTOR COVERED CALL ETF - CAD ETF Hamilton Enhanced Multi-Sector Covered Call ETF - CAD
+5.39%0.77% 711 M€
12345

Company Profile

Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Sector
Pharmaceuticals
Calendar
05-15 - Ex-dividend date - 2.52 USD
More about the company

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quality

Quality

This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

ESG MSCI

ESG MSCI

The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

A
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
351.02USD
Average target price
351.69USD
Spread / Average Target
+0.19%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. ETFs Amgen Inc.

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition